Crystal modifications -3- (1H-indol-3-yl) -4- [2- (4-methyl-piperazin-1-yl) - quinazolin-4-yl] -pyrrole-2, 5-dione
Details for Australian Patent Application No. 2007309558 (hide)
International Classifications
Event Publications
23 April 2009 PCT application entered the National Phase
PCT publication WO2008/051440 Priority application(s): WO2008/051440
25 June 2009 Amendment Made
The nature of the amendment is: Amend the invention title to read Crystal modifications -3- (1H-indol-3-yl) -4- [2- (4-methyl-piperazin-1-yl) -quinazolin-4-yl] -pyrrole-2, 5-dione
24 May 2012 Application Accepted
Published as AU-B-2007309558
20 September 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007309567-Niacin receptor agonists, compositions containing such compounds and methods of treatment
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser